Vision Fund investment portfolio company Ventus Therapeutics's logo

Ventus Therapeutics is using computational tools to unlock elusive drug targets that address human disease.

Leadership
Marcelo Bigal
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas
Insights
Q&A
Why Ventus Therapeutics always puts patients first

For CEO Marcelo Bigal, it comes down to everyone understanding the company’s core mission

Vision Fund Team
Portrait of Vision Fund Director, EMEA, John Cassidy
John Cassidy
Director, EMEA
View Profile